These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 12580533)
1. Mechanism of cartilage destruction in osteoarthritis. Ishiguro N; Kojima T; Poole AR Nagoya J Med Sci; 2002 Nov; 65(3-4):73-84. PubMed ID: 12580533 [TBL] [Abstract][Full Text] [Related]
2. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis. Lohmander LS J Rheumatol Suppl; 1995 Feb; 43():75-7. PubMed ID: 7752145 [TBL] [Abstract][Full Text] [Related]
3. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270 [TBL] [Abstract][Full Text] [Related]
4. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis. Squires GR; Okouneff S; Ionescu M; Poole AR Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899 [TBL] [Abstract][Full Text] [Related]
5. Aggrecan degradation in osteoarthritis and rheumatoid arthritis. Lark MW; Bayne EK; Lohmander LS Acta Orthop Scand Suppl; 1995 Oct; 266():92-7. PubMed ID: 8553869 [No Abstract] [Full Text] [Related]
6. Bone morphogenetic protein and transforming growth factor beta inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1beta. Kaiser M; Haag J; Söder S; Bau B; Aigner T Arthritis Rheum; 2004 Nov; 50(11):3535-40. PubMed ID: 15529348 [TBL] [Abstract][Full Text] [Related]
8. Immune responses to cartilage link protein and the G1 domain of proteoglycan aggrecan in patients with osteoarthritis. Guerassimov A; Zhang Y; Cartman A; Rosenberg LC; Esdaile J; Fitzcharles MA; Poole AR Arthritis Rheum; 1999 Mar; 42(3):527-33. PubMed ID: 10088776 [TBL] [Abstract][Full Text] [Related]
10. The matrix metalloproteinases as pharmacological target in osteoarthritis: statins may be of therapeutic benefit. Wu YS; Hu YY; Yang RF; Wang Z; Wei YY Med Hypotheses; 2007; 69(3):557-9. PubMed ID: 17360129 [TBL] [Abstract][Full Text] [Related]
11. The serine protease inhibitor trappin-2 is present in cartilage and synovial fluid in osteoarthritis. Jaovisidha K; Etim A; Yamakawa K; Masuda I; Gohr CM; Wakim BT; Boonapatcharoen N; Ninomiya J; Rosenthal AK J Rheumatol; 2006 Feb; 33(2):318-25. PubMed ID: 16465664 [TBL] [Abstract][Full Text] [Related]
12. [Biochemical markers of bone turnover. New aspect. Biomarkers of cartilage metabolism]. Okano T; Koike T Clin Calcium; 2009 Aug; 19(8):1149-58. PubMed ID: 19638699 [TBL] [Abstract][Full Text] [Related]
13. Spontaneous and experimental osteoarthritis in dog: similarities and differences in proteoglycan levels. Liu W; Burton-Wurster N; Glant TT; Tashman S; Sumner DR; Kamath RV; Lust G; Kimura JH; Cs-Szabo G J Orthop Res; 2003 Jul; 21(4):730-7. PubMed ID: 12798075 [TBL] [Abstract][Full Text] [Related]
14. Update on the biology of the chondrocyte and new approaches to treating cartilage diseases. Goldring MB Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):1003-25. PubMed ID: 16980220 [TBL] [Abstract][Full Text] [Related]
15. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis. Sabatini M; Lesur C; Thomas M; Chomel A; Anract P; de Nanteuil G; Pastoureau P Arthritis Rheum; 2005 Jan; 52(1):171-80. PubMed ID: 15641085 [TBL] [Abstract][Full Text] [Related]
16. Differential adherence of osteoarthritis and rheumatoid arthritis synovial fibroblasts to cartilage and bone matrix proteins and its implication for osteoarthritis pathogenesis. Schedel J; Wenglén C; Distler O; Müller-Ladner U; Schölmerich J; Heinegård D; Krenn V Scand J Immunol; 2004 Nov; 60(5):514-23. PubMed ID: 15541045 [TBL] [Abstract][Full Text] [Related]
17. Altered patterns and synthesis of extracellular matrix macromolecules in early osteoarthritis. Lorenzo P; Bayliss MT; Heinegård D Matrix Biol; 2004 Oct; 23(6):381-91. PubMed ID: 15533759 [TBL] [Abstract][Full Text] [Related]
18. Biomarkers of cartilage turnover. Part 2: Non-collagenous markers. Garvican ER; Vaughan-Thomas A; Clegg PD; Innes JF Vet J; 2010 Jul; 185(1):43-9. PubMed ID: 20488734 [TBL] [Abstract][Full Text] [Related]
19. [Progress of research in osteoarthritis. An overview of the recent knowledge on osteoarthritis: pathogenesis, evaluation and therapies]. Kimura T Clin Calcium; 2009 Nov; 19(11):1565-71. PubMed ID: 19880987 [TBL] [Abstract][Full Text] [Related]
20. Catabolic stress induces features of chondrocyte senescence through overexpression of caveolin 1: possible involvement of caveolin 1-induced down-regulation of articular chondrocytes in the pathogenesis of osteoarthritis. Dai SM; Shan ZZ; Nakamura H; Masuko-Hongo K; Kato T; Nishioka K; Yudoh K Arthritis Rheum; 2006 Mar; 54(3):818-31. PubMed ID: 16508959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]